Braxia Scientific Corp.

PNK:BRAXF

$0.004 USD

$0.0 (-4.76%)

Volume
26.26K
Average Volume
121.56K
Market Capitalization
$1.13M
P/E Ratio
-0.67
Dividend Yield
0.00%
Price Target
$
Year High
$0.01
Year Low
$0.00
Payout Ratio
$0.00
Current Ratio
$0.18

Industry, Sector & symbol

Stock Exchange Other OTC
CEO Dr. Roger S. McIntyre FRCPC, M.D.
Industry Biotechnology
Sector Healthcare
Current Symbol BRAXF
CUSIP 105736102
CIK None
Web https://www.braxiascientific.com
Phone 416-430-9619
Currency USD
Employees None
Country CA

Liquidity

Debt-to-Equity Ratio -0.30
Payout Ratio 0.00
Current Ratio 0.18
Quick Ratio 0.18
Cash Ratio 0.06

Sales & Book Value

Annual Sales $1.88M
Price / Sales 0.84
Cash Flow 0.00
Price / Cash Flow -1.11
Price / Book -3.60

Price Target and Rating

Average Stock Price Forecast $
High Stock Price Forecast $
Low Stock Price Forecast $
Forecast Upside/Downside %
Consensus Rating Sell
Rating Score(0-5) 2
Research Coverage 0 Analysts

Profitability

EPS (Most Recent Fiscal Year) $-0.0575
Trailing P/E Ratio -0.67
PEG Ratio -0.05
P/E Growth -0.05
Net Income $-13.14M
Net Margin -117.51%
Pretax Margin -116.81%
Return on Equity -611.01%
Return on Assets -84.76%

Financials Score

AltmanZ Score -76.39
Piotroski Score 3.00
Working Capital -1.81M
Total Assets 2.34M
Ebit -4.22M
Market Cap 849.84K
Total Liabilities 2.7M

Poll Results

About Braxia Scientific Corp. (PNK:BRAXF) Stock

Braxia Scientific Corp. operates as a medical research company with clinics that provide ketamine treatments for persons with depression and related disorders. It is also involved in the research activities related to discovering and commercializing novel drugs and delivery methods; and developing ketamine and psilocybin derivatives and other psychedelic products from its IP development platform. In addition, the company owns and operates multidisciplinary clinics for the treatment of mental health disorders. Braxia Scientific Corp. is headquartered in Mississauga, Ontario. ...

Braxia Scientific Announces Change in Directors and CEO

2024-11-18 18:33:00

Toronto, Ontario--(Newsfile Corp. - November 18, 2024) - Braxia Scientific Corp. (CSE: BRAX) (OTC Pink: BRAXF) (FSE: 4960) ("Braxia", or the "Company") announced that Jerry Habuda has resigned as a director effective November 12, 2024. Peter Rizakos was appointed on the same date by the remaining directors.

Braxia Scientific Announces Voting Results from the Annual General and Special Meeting of Shareholders

2024-10-10 07:23:00

Sale of Company's Assets Approved Toronto, Ontario--(Newsfile Corp. - October 10, 2024) - Braxia Scientific Corp. (CSE: BRAX) (OTC Pink: BRAXF) (FSE: 4960) ("Braxia", or the "Company"), is pleased to announce the voting results from its Annual General and Special Meeting of Shareholders held on Wednesday, October 9, 2024. A total of 9.9% of the issued and outstanding common shares of the Company were represented either in person or by proxy at the meeting.

Braxia Announces Annual General and Special Meeting

2024-09-10 18:36:00

Toronto, Ontario--(Newsfile Corp. - September 10, 2024) - Braxia Scientific Corp. (CSE: BRAX) (OTC Pink: BRAXF) (FSE: 4960) ("Braxia Scientific", or the "Company") announced today that an annual general and special meeting (the "Meeting") of the common shareholders will be held in person at 10:00 a.m. (Toronto time) on Wednesday October 9, 2024, at 1430 Hurontario Street, Mississauga, Ontario, L5G 3H4.

Braxia Scientific Announces Cease Trade Order

2024-08-05 18:00:00

Toronto, Ontario--(Newsfile Corp. - August 5, 2024) - Braxia Scientific Corp. (CSE: BRAX) (OTC Pink: BRAXF) (FWB: 4960), ("Braxia Scientific", or the "Company"), today announced that the Ontario Securities Commission (the "OSC") issued a failure-to-file cease trade order (the "FFCTO") to the Company on August 2, 2024. The FFCTO is a result of the Company's failure to file its audited annual financial statements (the "Annual Financial Statements"), management discussion and analysis ("MD&A") and certificates of the Chief Executive Officer and Chief Financial Officer (collectively, the "Annual Documents") for the year ended March 31, 2024.

Braxia Scientific Provides Update on Application for Management Cease Trade Order

2024-07-25 17:44:00

Toronto, Ontario--(Newsfile Corp. - July 25, 2024) - Braxia Scientific Corp. (CSE: BRAX) (OTC Pink: BRAXF) (FSE: 4960) ("Braxia Scientific", or the "Company"), today announced further to its press release of July 15, 2024, that the Ontario Securities Commission (the "OSC") has denied the Company's application for a voluntary management cease trade order (the "MCTO") under National Policy 12-203 Management Cease Trade Orders ("NP 12-203") as the Company does not meet the criteria for an MCTO. The Company previously reported it had filed the application for a voluntary MCTO with the OSC due to an anticipated delay in filing its audited annual financial statements and management discussion & analysis for the financial year ended March 31, 2024, and the CEO and CFO certificates, all as required by National Instrument 51-102 - Continuous Disclosure Obligations and National Instrument 52-109 - Certification of Disclosure in Issuers' Annual and Interim Filings (collectively, the "Documents").

Frequently Asked Questions

What is the current Braxia Scientific Corp. (BRAXF) stock price?

Braxia Scientific Corp.(PNK:BRAXF) stock price is $0.004 in the last trading session. During the trading session, BRAXF stock reached the peak price of $0.009 while $0.001 was the lowest point it dropped to. The percentage change in BRAXF stock occurred in the recent session was --4.76% while the dollar amount for the price change in BRAXF stock was -$-0.0.

BRAXF's industry and sector of operation?

The PNK listed BRAXF is part of Biotechnology industry that operates in the broader Healthcare sector.

Who are the executives of BRAXF?

Dr. Roger S. McIntyre FRCPC, M.D. | Chairman & Chief Executive Officer
Mr. Peter Rizakos | Chief Financial Officer & Director
|
|
|

How many employees does BRAXF have?

Number of BRAXF employees currently stands at None. BRAXF operates from 1430 Hurontario Street, Mississauga, ON L5G 3H4, CA.

Link for BRAXF official website?

Official Website of BRAXF is: https://www.braxiascientific.com

How do I contact BRAXF?

BRAXF could be contacted at phone #416-430-9619 and can also be accessed through its website. BRAXF operates from 1430 Hurontario Street, Mississauga, ON L5G 3H4, CA.

How many shares of BRAXF are traded daily?

The average number of BRAXF shares traded daily for last 3 months was 121.56K.

What is the market cap of BRAXF currently?

The market value of BRAXF currently stands at $1.13M with its latest stock price at $0.004